改善慢阻肺合并心血管疾病患者结局的研究议程:美国胸科学会官方研究声明
美国胸科学会组织国际多学科委员会(含患者倡导者),通过文献回顾和改良德尔菲法对慢阻肺合并心血管疾病(心衰、动脉粥样硬化性血管病、房颤)的诊断与管理研究议题进行优先级排序。共17名专家参与,所有投票均达到法定人数(>80%),两轮投票后17个议题中12个达成≥70%共识,最高优先级为「开展以患者为中心结局、同时收集肺与心脏数据的实用临床试验」,并强调将健康公平嵌入所有研究。
要点
- 优先开展同时收集肺与心脏数据的实用临床试验。
- 健康公平应嵌入所有相关研究议题。
- 研究缺口涵盖从基础机制到实施科学的转化全链条。
核心结论
- 提出优先研究议程,旨在激发高影响力研究以改善慢阻肺合并心血管疾病患者的结局。
研究设计与样本
- 文献检索后由委员会联合主席审阅参考文献,国际多学科委员会(含患者倡导者)以虚拟会议审阅证据并识别研究议题,采用改良德尔菲法实时优先排序。
- 17名专家参与,所有投票均达到法定人数(>80%)。
主要发现
- 研究缺口涵盖转化科学全谱:疾病机制、流行病学、亚表型、诊断与管理、临床试验、照护提供、药物可及性/依从性/副作用、危险因素缓解、心肺康复、健康公平。
- 两轮投票后,17个议题中12个达成≥70%共识。
- 综合Likert评分范围为-15至25。
- 最高优先级议题为「开展以患者为中心结局、同时收集肺与心脏数据的实用临床试验」。
- 健康公平被确定为应嵌入所有研究的重要议题。
关键数值与推荐
- 17名专家参与,所有投票均达到法定人数(>80%)。
- 17个议题中12个在两轮投票后达成≥70%共识。
- 综合Likert评分范围为-15至25。
- 最高优先级议题为「开展以患者为中心结局、同时收集肺与心脏数据的实用临床试验」。
临床怎么用
- 临床与研究团队可参照该议程设计同时采集肺与心脏数据的实用临床试验。
- 在慢阻肺合并心血管疾病的研究与照护中应纳入健康公平考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Individuals with chronic obstructive pulmonary disease (COPD) are often at risk for or have comorbid cardiovascular disease and are likely to die of cardiovascular-related causes. Objectives: To prioritize a list of research topics related to the diagnosis and management of patients with COPD and comorbid cardiovascular diseases (heart failure, atherosclerotic vascular disease, and atrial fibrillation) by summarizing existing evidence and using consensus-based methods. Methods: A literature search was performed. References were reviewed by committee co-chairs. An international, multidisciplinary committee, including a patient advocate, met virtually to review evidence and identify research topics. A modified Delphi approach was used to prioritize topics in real time on the basis of their potential for advancing the field. Results: Gaps spanned the translational science spectrum from basic science to implementation: 1) disease mechanisms; 2) epidemiology; 3) subphenotyping; 4) diagnosis and management; 5) clinical trials; 6) care delivery; 7) medication access, adherence, and side effects; 8) risk factor mitigation; 9) cardiac and pulmonary rehabilitation; and 10) health equity. Seventeen experts participated, and quorum was achieved for all votes (>80%). Of 17 topics, ≥70% agreement was achieved for 12 topics after two rounds of voting. The range of summative Likert scores was -15 to 25. The highest priority was "Conduct pragmatic clinical trials with patient-centered outcomes that collect both pulmonary and cardiac data elements." Health equity was identified as an important topic that should be embedded within all research. Conclusions: We propose a prioritized research agenda with the purpose of stimulating high-impact research that will hopefully improve outcomes among people with COPD and cardiovascular disease.
引用
- Myers LC, Quint JK, Hawkins NM, et al. A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2024. PMID: 39133888. doi:10.1164/rccm.202407-1320ST
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。